Diabetes Risk of Peripheral Neuropathy

Over 6,000 healthcare professionals from across Asia, Africa and the Middle East were brought together at a ‘Demystifying Neuropathy Forum’ organised by P & G Health. The online event saw presentations on the latest clinical guidance and research findings on screening and management of Peripheral Neuropathy. Peripheral Neuropathy (PN) is a chronic clinical condition, wherein […]

Questions Around Weight Loss Drugs

Tirzepatide, sold under the brand name Mounjaro, is an anti-diabetic medication used for the treatment of type 2 diabetes. It is administered through subcutaneous injections (under the skin). Semaglutide, sold under the brand names Ozempic, Wegovy and Rybelsus, is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management. A study into weight […]

Combating NCDs in Namibia

Namibia’s Minister of Health and Social Services Kalumbi Shangula called for a need to ramp up interventions and strategies aimed at combating non-communicable diseases (NCDs) in the country. He has highlighted the promotion of physical activity and adopting a healthy diet, specifically targeting the reduction of salt, sugar, and trans-fat intake to address obesity and […]

Diabetes and Tuberculosis (TB)

With 1.6 million People with TB and Diabetes the World Health Organisation has published advice under the heading ‘Invest for impact’. Diabetes is associated with about twice the risk of tuberculosis (TB) disease and a higher risk of multidrug-resistant TB. People with both TB and diabetes are twice as likely to die during TB treatment […]

Diabetes and Heart Failure

Diabetes appears to play a critical role in the progression from preclinical heart failure to overt heart failure, according to a poster presented at the ADA Scientific Sessions. The researchers, Dr. Justin B. Echouffo Tcheugi, and colleagues, observed 383 heart failure events and 730 deaths over the 8.6 years of follow-up. Overall, the study showed […]

Call to Action on Forgotten T1 Complications

The call came from Dr Peter Rossing, head of complications research at Steno Diabetes Center in Copenhagen. He claimed that type 1 diabetes (T1D) patients with Chronic Kidney Disease (CKD) have largely been forgotten. While the management of chronic kidney disease (CKD) in patients with diabetes has been transformed in recent years, studies have focused […]